Bioelectronics Corp is selling for 4.0E-4 as of the 29th of January 2026. This is a 33.33% increase since the beginning of the trading day. The stock's lowest day price was 4.0E-4. Bioelectronics Corp has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 31st of October 2025 and ending today, the 29th of January 2026. Click here to learn more.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. The company has 24.71 B outstanding shares. More on Bioelectronics Corp
Bioelectronics Corp [BIEL] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioelectronics Corp's market, we take the total number of its shares issued and multiply it by Bioelectronics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioelectronics Corp conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 24.71 B outstanding shares.
Bioelectronics Corp currently holds about 925 in cash with (320.3 K) of positive cash flow from operations.
Check Bioelectronics Corp Probability Of Bankruptcy
The company had not issued any dividends in recent years. BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.The quote for Bioelectronics Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bioelectronics Corp please contact Kelly Whelan at 301 874 4890 or go to https://www.bielcorp.com.
Bioelectronics Corp Investment Alerts
Bioelectronics Corp is way too risky over 90 days horizon
Bioelectronics Corp has some characteristics of a very speculative penny stock
Bioelectronics Corp appears to be risky and price may revert if volatility continues
Bioelectronics Corp has high likelihood to experience some financial distress in the next 2 years
Bioelectronics Corp currently holds 13.34 M in liabilities. Bioelectronics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioelectronics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Bioelectronics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioelectronics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioelectronics to invest in growth at high rates of return. When we think about Bioelectronics Corp's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.61 M. Net Loss for the year was (289.82 K) with profit before overhead, payroll, taxes, and interest of 795.53 K.
Bioelectronics Corp currently holds about 925 in cash with (320.3 K) of positive cash flow from operations.
Bioelectronics Corp Thematic Classifications
In addition to having Bioelectronics Corp pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioelectronics Corp's market, we take the total number of its shares issued and multiply it by Bioelectronics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Bioelectronics Profitablity
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.
Technical Drivers
As of the 29th of January, Bioelectronics Corp shows the Downside Deviation of 25.62, risk adjusted performance of 0.0969, and Mean Deviation of 15.3. Bioelectronics Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bioelectronics Corpjensen alpha, as well as the relationship between the potential upside and skewness to decide if Bioelectronics Corp is priced correctly, providing market reflects its regular price of 4.0E-4 per share. As Bioelectronics Corp appears to be a penny stock we also recommend to validate its total risk alpha numbers.
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioelectronics Corp Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Bioelectronics Corp price patterns.
Bioelectronics Corp Outstanding Bonds
Bioelectronics Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioelectronics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioelectronics bonds can be classified according to their maturity, which is the date when Bioelectronics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Bioelectronics Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioelectronics Corp pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Bioelectronics Corp's time-series forecasting models are one of many Bioelectronics Corp's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioelectronics Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Bioelectronics Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Watchlist Optimization Now
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.
